Allergy Therapeutics shares jump after US vaccine approva

Shares in Allergy Therapeutics (LON:AGY) jumped after the US Food and Drug Administration (FDA) lifted its five-year hold on the company’s clinical development programme for a grass pollen vaccine.
WT news feed